Vericel Announces Expansion of MACI Coverage by UnitedHealthcare

UnitedHealthcare expanded its medical policy for Vericel's MACI® autologous cultured chondrocytes on porcine collagen membrane to include coverage for patients with symptomatic full-thickness cartilage defects in the patella and multiple cartilage defects in the knee.

UnitedHealthcare is the largest commercial payor in the U.S., covering...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us